{{Rsnum
|rsid=6807064
|Gene=ATP2B2
|Chromosome=3
|position=10494087
|Orientation=plus
|GMAF=0.3287
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ATP2B2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 59.8 | 35.7 | 4.5
| HCB | 62.5 | 36.8 | 0.7
| JPT | 69.9 | 27.4 | 2.7
| YRI | 23.3 | 47.9 | 28.8
| ASW | 23.6 | 47.3 | 29.1
| CHB | 62.5 | 36.8 | 0.7
| CHD | 64.8 | 30.5 | 4.8
| GIH | 45.9 | 44.9 | 9.2
| LWK | 32.4 | 49.1 | 18.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 27.6 | 38.2 | 34.2
| TSI | 43.0 | 46.0 | 11.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=1E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs6807064
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 3p25.3; Reported Gene(s): ATP2B2; Risk Allele: rs6807064-?); (p-value= 0.0000001).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740312
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6807064
|overall_frequency_n=48
|overall_frequency_d=128
|overall_frequency=0.375
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}